Dissolution Optimization
Dissolution Optimization is a systematic pharmaceutical development strategy that enhances the rate and extent of drug release from an oral dosage form by modifying formulation or process parameters to achieve targeted in vitro or in vivo dissolution profiles.
338
Publications
15.9K
Citations
1.3K
Authors
430
Institutions
Publications per year
2017–2026
89
Parents
338
1–5 of 338
1.3K
5
h-index
4
h-index
4
h-index
Merck & Co., Inc., Rahway, NJ, USA (United States), United States
3 publications · 138 citations
3
h-index
3
h-index
1–5 of 1.3K
430

Cairo University
Giza, Egypt
10 h-index
24 publications
2.4K citations
Heinrich Heine University Düsseldorf
Düsseldorf, Germany
5 h-index
11 publications
478 citations
Pfizer (United States)
New York, United States
5 h-index
9 publications
398 citations
United States Military Academy
West Point, United States
5 h-index
12 publications
447 citations
Freie Universität Berlin
Berlin, Germany
5 h-index
10 publications
655 citations
University of Sunderland
Sunderland, United Kingdom
4 h-index
10 publications
328 citations
Shenyang Pharmaceutical University
Shenyang, China
4 h-index
24 publications
702 citations

Chung-Ang University
Seoul, South Korea
4 h-index
30 publications
1.1K citations
1–8 of 430
46 publications · 2.9K citations
30
h-index
32 publications · 1.5K citations
20
h-index
18 publications · 899 citations
17
h-index
EJPB · 17 publications · 1.7K citations
17
h-index
19 publications · 1K citations
15
h-index
1–5